Evidence map›Paper›PMID 19353280›Full record

ArticleCancer causes & control : CCC2009

Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey.

Elisa V Bandera, Melony G Williams, Camelia Sima, Sharon Bayuga, Katherine Pulick, Homer Wilcox, Robert Soslow, Ann G Zauber, Sara H Olson

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 5 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 5 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. In vitro effects of polyphenols on colorectal cancer cells.World journal of gastrointestinal oncology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Elisa V BanderaThe Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA. elisa.bandera@umdnj.edu
Melony G Williams
Camelia Sima
Sharon Bayuga
Katherine Pulick
Homer Wilcox
Robert Soslow
Ann G Zauber
Sara H Olson
Memorial Sloan Kettering Cancer Center · USJohnson University · USNew Jersey Department of Health · USRutgers Cancer Institute of New Jersey

Funding

ESTROGEN, DIET, GENETICS AND ENDOMETRIAL CANCERR01CA083918 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI OLSON, SARA H · 2001 to 2005
$2.5M
Phytoestrogens, alcohol, and endometrial cancer riskK07CA095666 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI BANDERA, ELISA V · 2003 to 2007
$672k
NCI NIH HHS K07 CA095666NCI NIH HHS R01 CA083918NCI NIH HHS R01CA83918
6 · The paper itself

Abstract

Phytoestrogens have been shown to exert anti-estrogenic and estrogenic effects in some tissues, including the breast. However, only a few studies have evaluated their role in endometrial cancer risk. We evaluated this association in a population-based case-control study in New Jersey. A total of 424 cases and 398 controls completed an interview, including a food frequency questionnaire with supplemental questions for phytoestrogen foods. Risk estimates were derived using an unconditional logistic regression, adjusting for major risk factors for endometrial cancer. There was some suggestion of a decreased risk with quercetin intake (OR: 0.65; 95% CI: 0.41-1.01 for the highest compared to the lowest quartile; p for trend: 0.02). We found a limited evidence of an association with any of the lignans evaluated, total lignans, coumestrol, individual isoflavones, total isoflavones, or total phytoestrogens. However, there was some suggestion of an inverse association with total isoflavone intake limited to lean women (BMI <25; OR for the highest tertile: 0.50; 95% CI: 0.25-0.98) and those with a waist-to-hip ratio <or=0.85 (OR: 0.59; 95% CI: 0.33-1.05). There was no evidence of effect modification by HRT use. This study suggests a reduction in endometrial cancer risk with quercetin intake and with isoflavone intake in lean women.

Indexed as

AgedBody Mass IndexCase-Control StudiesCoumestrolEatingEndometrial NeoplasmsEstrogen Replacement TherapyFemaleFoodHumansInterviews as TopicIsoflavonesLignansMiddle AgedNew JerseyPhytoestrogensCoumestrolIsoflavonesLignansPhytoestrogensQuercetin

Identifiers

PMID19353280
PMCPMC2761755
OpenAlexW1974240813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.